Objective: Henoch-Schönlein purpura (HSP) is the most common vasculitis in children but it is not exceptional in adults. Increased familial occurrence supports a genetic predisposition for HSP. In this context, an association with the human leukocyte antigen-HLA-DRB1*01 phenotype has been suggested in Caucasian individuals with HSP. However, data on the potential association of HSP with HLA-DRB1*01 were based on small case series. To further investigate this issue, we performed HLA-DRB1 genotyping of the largest series of HSP patients ever assessed for genetic studies in Caucasians. Methods: 342 Spanish patients diagnosed with HSP fulfilling the American College of Rheumatology and the Michel et al classification criteria, and 303 sex and ethnically matched controls were assessed. HLA-DRB1 alleles were determined using a PCR-Sequence-Specific-Oligonucleotide Probe (PCR-SSOP) method. Results: A statistically significant increase of HLA-DRB1*01 in HSP patients when compared with controls was found (43% vs 7%, respectively; p<0.001; odds ratio-OR=2.03 [1.43-2.87]). It was due to the increased frequency of HLA-DRB1*0103 phenotype in HSP (14% vs 2%; p<0.001; OR=8.27 [3.46-23.9]). These results remained statistically significant after adjusting for Bonferroni correction. In contrast, a statistically significant decreased frequency of the HLA-DRB1*0301 phenotype was observed in patients compared to controls (5.6% vs 18.1%, respectively; p<0.001, OR=0.26 [0.14-0.47]), even after adjustment for Bonferroni correction. No HLA-DRB1 association with specific features of the disease was found. Conclusion: Our study confirms an association of HSP with HLA-DRB1*01 in Caucasians. Also, a protective effect against the development of HSP appears to exist in Caucasians carrying the HLA-DRB1*03 phenotype. This article is protected by copyright. All rights reserved.
Objective: Henoch-Schönlein purpura (HSP) is the most common vasculitis in children but it is not exceptional in adults. Increased familial occurrence supports a genetic predisposition for HSP. In this context, an association with the human leukocyte antigen-HLA-DRB1*01 phenotype has been suggested in Caucasian individuals with HSP. However, data on the potential association of HSP with HLA-DRB1*01 were based on small case series. To further investigate this issue, we performed HLA-DRB1 genotyping of the largest series of HSP patients ever assessed for genetic studies in Caucasians. Methods: 342 Spanish patients diagnosed with HSP fulfilling the American College of Rheumatology and the Michel et al classification criteria, and 303 sex and ethnically matched controls were assessed. HLA-DRB1 alleles were determined using a PCR-Sequence-Specific-Oligonucleotide Probe (PCR-SSOP) method. Results: A statistically significant increase of HLA-DRB1*01 in HSP patients when compared with controls was found (43% vs 7%, respectively; p<0.001; odds ratio-OR=2.03 [1.43-2.87]). It was due to the increased frequency of HLA-DRB1*0103 phenotype in HSP (14% vs 2%; p<0.001; OR=8.27 [3.46-23.9]). These results remained statistically significant after adjusting for Bonferroni correction. In contrast, a statistically significant decreased frequency of the HLA-DRB1*0301 phenotype was observed in patients compared to controls (5.6% vs 18.1%, respectively; p<0.001, OR=0.26 [0.14-0.47]), even after adjustment for Bonferroni correction. No HLA-DRB1 association with specific features of the disease was found. Conclusion: Our study confirms an association of HSP with HLA-DRB1*01 in Caucasians. Also, a protective effect against the development of HSP appears to exist in Caucasians carrying the HLA-DRB1*03 phenotype. This article is protected by copyright. All rights reserved.
Authors: Mikael Koskela; Julia Nihtilä; Elisa Ylinen; Kaija-Leena Kolho; Matti Nuutinen; Jarmo Ritari; Timo Jahnukainen Journal: Pediatr Nephrol Date: 2021-02-16 Impact factor: 3.714
Authors: Raquel López-Mejías; Fernanda Genre; Belén Sevilla Pérez; Santos Castañeda; Norberto Ortego-Centeno; Javier Llorca; Begoña Ubilla; Sara Remuzgo-Martínez; Verónica Mijares; Trinitario Pina; Vanesa Calvo-Río; Ana Márquez; José A Miranda-Filloy; Antonio Navas Parejo; Marta Conde-Jaldón; Lourdes Ortiz-Fernández; Diego Argila; Maximiliano Aragües; Esteban Rubio; Manuel León Luque; Juan María Blanco-Madrigal; Eva Galíndez-Aguirregoikoa; Francisca González Escribano; J Gonzalo Ocejo-Vinyals; Javier Martín; Ricardo Blanco; Miguel A González-Gay Journal: Arthritis Res Ther Date: 2015-04-14 Impact factor: 5.156
Authors: Raquel López-Mejías; F David Carmona; Santos Castañeda; Fernanda Genre; Sara Remuzgo-Martínez; Belén Sevilla-Perez; Norberto Ortego-Centeno; Javier Llorca; Begoña Ubilla; Verónica Mijares; Trinitario Pina; José A Miranda-Filloy; Antonio Navas Parejo; Diego de Argila; Maximiliano Aragües; Esteban Rubio; Manuel León Luque; Juan María Blanco-Madrigal; Eva Galíndez-Aguirregoikoa; David Jayne; Ricardo Blanco; Javier Martín; Miguel A González-Gay Journal: Sci Rep Date: 2017-07-11 Impact factor: 4.379
Authors: F David Carmona; Patrick Coit; Güher Saruhan-Direskeneli; José Hernández-Rodríguez; María C Cid; Roser Solans; Santos Castañeda; Augusto Vaglio; Haner Direskeneli; Peter A Merkel; Luigi Boiardi; Carlo Salvarani; Miguel A González-Gay; Javier Martín; Amr H Sawalha Journal: Sci Rep Date: 2017-03-09 Impact factor: 4.379
Authors: Chen Tang; Daphne Scaramangas-Plumley; Cynthia C Nast; Zab Mosenifar; Marc A Edelstein; Michael Weisman Journal: Am J Case Rep Date: 2017-02-08
Authors: Raquel López-Mejías; Fernanda Genre; Sara Remuzgo-Martínez; Belén Sevilla Pérez; Santos Castañeda; Javier Llorca; Norberto Ortego-Centeno; Begoña Ubilla; Verónica Mijares; Trinitario Pina; Vanesa Calvo-Río; Natalia Palmou; José A Miranda-Filloy; Antonio Navas Parejo; Diego Argila; Javier Sánchez-Pérez; Esteban Rubio; Manuel León Luque; Juan María Blanco-Madrigal; Eva Galíndez-Aguirregoikoa; J Gonzalo Ocejo-Vinyals; Javier Martín; Ricardo Blanco; Miguel A González-Gay Journal: Arthritis Res Ther Date: 2015-10-13 Impact factor: 5.156
Authors: Vanesa Calvo-Río; José Luis Hernández; Francisco Ortiz-Sanjuán; Javier Loricera; Natalia Palmou-Fontana; Maria C González-Vela; Domingo González-Lamuño; Marcos A González-López; Susana Armesto; Ricardo Blanco; Miguel A González-Gay Journal: Medicine (Baltimore) Date: 2016-07 Impact factor: 1.889